Barry Marshall, MD
Potential Financial Conflicts of Interest: None disclosed.
Requests for Single Reprints: Barry Marshall, MD, The University of Western Australia, School of Biomedical, Biomolecular, and Chemical Sciences, Microbiology & Immunology, H. pylori Laboratory, Room 2.13 L Block, Queen Elizabeth II Medical Centre, Nedlands 6009, Australia.
Marshall B.; Sequential Therapy for Helicobacter pylori: A Worthwhile Effort for Your Patients. Ann Intern Med. 2008;148:962-963. doi: 10.7326/0003-4819-148-12-200806170-00227
Download citation file:
Published: Ann Intern Med. 2008;148(12):962-963.
Sequential therapy for Helicobacter pylori refers to the idea of adding more antibiotics to the treatment regimen but giving them in sequence rather than giving all 4 drugs together. Typically, this involves an initial 5-day therapy with a benign combination (for example, pantoprazole, 40 mg, with amoxicillin, 1 g, twice daily) followed by 5 days of 2 further antibiotics plus a proton-pump inhibitor (PPI) (for example, clarithromycin, 500 mg, and tinidazole, 500 mg, plus pantoprazole, 40 mg, twice daily), as shown below:
to gain full access to the content and tools.
Learn more about subscription options.
Register Now for a free account.
Results provided by:
Copyright © 2016 American College of Physicians. All Rights Reserved.
Print ISSN: 0003-4819 | Online ISSN: 1539-3704
Conditions of Use
This PDF is available to Subscribers Only